78 related articles for article (PubMed ID: 25547405)
1. Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations.
Theron A; Prudent R; Nolte E; van den Bout I; Punchoo R; Marais S; du Toit P; Hlophe Y; van Papendorp D; Lafanechère L; Joubert A
Cancer Chemother Pharmacol; 2015 Feb; 75(2):431-7. PubMed ID: 25547405
[TBL] [Abstract][Full Text] [Related]
2. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
[TBL] [Abstract][Full Text] [Related]
3. Sulphamoylated 2-methoxyestradiol analogues induce apoptosis in adenocarcinoma cell lines.
Visagie M; Theron A; Mqoco T; Vieira W; Prudent R; Martinez A; Lafanechère L; Joubert A
PLoS One; 2013; 8(9):e71935. PubMed ID: 24039728
[TBL] [Abstract][Full Text] [Related]
4. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A
Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-methoxyestradiol analogues with antitumor activity.
Tinley TL; Leal RM; Randall-Hlubek DA; Cessac JW; Wilkens LR; Rao PN; Mooberry SL
Cancer Res; 2003 Apr; 63(7):1538-49. PubMed ID: 12670902
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.
Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R
Top Curr Chem (Cham); 2019 May; 377(3):15. PubMed ID: 31073777
[TBL] [Abstract][Full Text] [Related]
7. 2-methoxyestradiol induces morpho-functional changes and impairs the microtubular system in mouse neuroblastoma and rat glioma cells.
Manca P; Chisu V
Arch Ital Biol; 2010 Mar; 148(1):11-21. PubMed ID: 20426250
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
[TBL] [Abstract][Full Text] [Related]
9. Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization.
Edsall AB; Mohanakrishnan AK; Yang D; Fanwick PE; Hamel E; Hanson AD; Agoston GE; Cushman M
J Med Chem; 2004 Oct; 47(21):5126-39. PubMed ID: 15456256
[TBL] [Abstract][Full Text] [Related]
10. YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance.
Zhao H; Quan H; Xie C; Xu Y; Xie F; Hu Y; Lou L
Cancer Lett; 2012 Jan; 314(1):54-62. PubMed ID: 21982683
[TBL] [Abstract][Full Text] [Related]
11. A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity.
Zheng YB; Gong JH; Liu XJ; Wu SY; Li Y; Xu XD; Shang BY; Zhou JM; Zhu ZL; Si SY; Zhen YS
Sci Rep; 2016 Aug; 6():31472. PubMed ID: 27510727
[TBL] [Abstract][Full Text] [Related]
12. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of cyclopropylamide analogues of combretastatin-A4 as novel microtubule-stabilizing agents.
Chen H; Li Y; Sheng C; Lv Z; Dong G; Wang T; Liu J; Zhang M; Li L; Zhang T; Geng D; Niu C; Li K
J Med Chem; 2013 Feb; 56(3):685-99. PubMed ID: 23356786
[TBL] [Abstract][Full Text] [Related]
14. The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
Greene LM; Nathwani SM; Bright SA; Fayne D; Croke A; Gagliardi M; McElligott AM; O'Connor L; Carr M; Keely NO; O'Boyle NM; Carroll P; Sarkadi B; Conneally E; Lloyd DG; Lawler M; Meegan MJ; Zisterer DM
J Pharmacol Exp Ther; 2010 Nov; 335(2):302-13. PubMed ID: 20699436
[TBL] [Abstract][Full Text] [Related]
15. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
[TBL] [Abstract][Full Text] [Related]
16. 4-Amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole (DAT1): a cytotoxic agent towards cancer cells and a probe for tubulin-microtubule system.
Sengupta S; Smitha SL; Thomas NE; Santhoshkumar TR; Devi SK; Sreejalekshmi KG; Rajasekharan KN
Br J Pharmacol; 2005 Aug; 145(8):1076-83. PubMed ID: 15951833
[TBL] [Abstract][Full Text] [Related]
17. 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.
Liu J; Wang X; Liu P; Deng R; Lei M; Chen W; Hu L
Bioorg Med Chem; 2013 Jul; 21(14):4279-87. PubMed ID: 23683834
[TBL] [Abstract][Full Text] [Related]
18. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
ter Haar E; Hamel E; Balachandran R; Day BW
Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
[TBL] [Abstract][Full Text] [Related]
19. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]